Same Indication

Irbesartan vs Trastuzumab

Irbesartan vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Irbesartan and Trastuzumab.

Mechanism of Action

Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Irbesartan — 11-15 hours; Trastuzumab — 28 days.

Chemical Properties

Molecular Formula: Irbesartan — C25H28N6O.

Molecular Weight: Irbesartan — 428.5320 g/mol.

Type: Irbesartan — Small molecule; Trastuzumab — Antibody.